La. Admin. Code tit. 51 § II-105

Current through Register Vol. 50, No. 11, November 20, 2024

Section II-105 - Reportable Diseases and Conditions [formerly paragraph 2:003]

A. It is hereby made the duty of every physician practicing medicine in the state of Louisiana to report to the state health officer, according to the requirements of this Section and utilizing the appropriate method(s) of reporting required under Subsection E of this Section, any case or suspected case of reportable disease or condition which he or she is attending, or has examined, or for which such physician has prescribed. The report shall be made promptly at the time the physician first visits, examines or prescribes for the patient, and such report shall state the name, age, sex, race, usual residence, place where the patient is to be found, the nature of the disease or condition and the date of onset, and the pregnancy status of the patient (if the pregnancy status is known and if it is clinically relevant to the disease or condition being reported). Reports of occupational disease/injury shall state contact information of the reporting person as well as the patients name, contact information, age (or date of birth), sex, race/ethnicity, usual residence, occupation, employer information, the nature of the disease or injury, and the date of diagnosis.

B. Any physician, whether Louisiana resident or nonresident, engaged in the practice of medicine at any federal installation or on any vessel, train or other common carrier, which enters any port, station or place in the state of Louisiana, is required to report as specified in Subsection A of this Section.

C. It shall be the duty of every osteopath, coroner, medical examiner, dentist, homeopath, infection control practitioner, laboratory director, medical records director, nurse, nurse midwife, nurse practitioner, pharmacist, physician assistant, podiatrist, poison control center, social worker, veterinarian, and any other health care professional to report a positive laboratory result or a confirmed or suspected case of any reportable disease or condition as required by this Section utilizing the appropriate method(s) of reporting required under Subsection E of this Section in which he or she has examined or evaluated, or for which he or she is attending or has knowledge. In the absence of a health care professional responsible for reporting as stated in the prior sentence (or a physician as referenced in Subsections A and B of this Section), it shall be the duty of the director, chief administrative officer, or other person in charge of any facility, program, or other entity that requires or conducts testing for reportable diseases or conditions, to report a positive laboratory result or a confirmed or suspected case of any reportable disease or condition as required by this Section utilizing the appropriate method(s) of reporting required under Subsection E of this Section.

D. The following diseases or conditions are hereby declared reportable with reporting requirements by class.

1. Class A Diseases or Conditions which Shall Require Reporting within 24 Hours

a. Class A diseases or conditions include diseases or conditions of major public health concern because of the severity of the disease or condition and the potential for epidemic spread. Class A diseases or conditions shall be reported to the Office of Public Health by telephone (or in another electronic format acceptable to the Office of Public Health) immediately upon recognition that a case, a suspected case, or a positive laboratory result is known. In addition, all cases of rare or exotic communicable diseases, unexplained death, unusual clusters of disease and all outbreaks shall be reported. Any class A disease or condition, rare or exotic communicable disease, unexplained death, or unusual cluster of disease and any disease outbreak, shall be reported to the Office of Public Health as soon as possible but no later than 24 hours from recognition that a case, a suspected case, a positive laboratory result, an unexplained death, an unusual cluster of disease, or a disease outbreak is known. The following diseases or conditions shall be classified as class A for reporting requirements:

i.Acinetobacter spp., carbapenem-resistant;

ii. acute flaccid paralysis, including acute flaccid myeltis;

iii. amoeba (free living) infection (including Acanthamoeba, Naegleria, Balamuthia and others;

iv. anthrax;

v. avian or novel strain influenza A (initial detection);

vi. botulism;

vii. brucellosis;

viii. Candida auris, as well as common misidentifications of C. auris (e.g., C. haemulonii, C. duobushaemulonii, C. famata, C. sake, C. lusitaniae, C. parapsilosis, C. catenulata, C. guilliermondii, and Rhodotorula glutinis);

ix. cholera;

x. Clostridium perfringens food-borne illness;

xi. Coronavirus Disease 2019 (COVID-19)/Infections with SARS-CoV-2;

xii. diphtheria;

xiii. Enterobacteriacea, carbenum-resistant;

xiv. fish or shellfish poisoning (domoic acid poisoning, neurotoxic shellfish poisoning, ciguatera, paralytic shellfish poisoning, scombroid);

xv. food-borne illness;

xvi. glanders (Burkholderia mallei);

xvii.Haemophilus influenzae (invasive infection);

xviii. influenza-associated mortality;

xix. measles (rubeola, imported or indigenous);

xx. melioidosis (Burkholderia pseudomallei);

xxi.Neisseria meningitidis (invasive infection); xxii. outbreaks of any infectious diseases;

xxiii. pertussis; xxiv. plague (Yersinia pestis);

xxv. poliomyelitis (paralytic and non-paralytic);

xxvi.Pseudomonas aeruginosa, carbapenem-resistant;

xxvii. Q fever (Coxiella burnettii);

xxviii. rabies (animal and human);

xxiv. ricin poisoning;

xxx. rubella (congenital syndrome);

xxxi. rubella (German measles);

xxxii. SARS (SARS-CoV-1 infection);

xxxiii. Staphylococcus aureus, vancomycin intermediate or resistant (VISA.VRSA);

xxxiv. staphylococcal enterotoxin B (SEB) pulmonary poisoning;

xxxv. smallpox;

xxxvi. tularemia (Francisella tularensis);

xxxvii. viral hemorrhagic fever (Ebola, Lassa, Marburg, Crimean Congo, etc.); and

xxxviii. yellow fever.

2. Class B Diseases or Conditions which Shall Require Reporting within One Business Day

a. Class B diseases or conditions include diseases or conditions of public health concern needing timely response because of potential for epidemic spread. The following class B diseases or conditions shall be reported to the Office of Public Health by the end of the next business day after the existence of a case, a suspected case, or a positive laboratory result is known:

i. anaplasmosis;

ii. arthropod-borne viral infections (including West Nile, Dengue, St. Louis, California, Eastern Equine, Western Equine, Chikungunya, Usutu, Zika, and others);

iii. aseptic meningitis;

iv. babesiosis;

v. Chagas disease;

vi. chancroid;

vii. cryptosporidiosis;

viii. cyclosporiasis;

ix.Escherichia coli, Shiga-toxin producing (STEC), including E. coli O157:H7;

x. granuloma inguinale;

xi. hantavirus (infection or pulmonary syndrome);

xii. hemolytic-uremic syndrome;

xiii. hepatitis A (acute illness);

xiv. hepatitis B (acute illness and carriage in pregnancy);

xv. hepatitis B (perinatal infection);

xvi. hepatitis C (acute illness);

xvii. hepatitis C (perinatal infection);

xviii. hepatitis E;

xix. herpes (neonatal);

xx. human immunodeficiency virus [(HIV), infection in pregnancy]^2,6;

xxi. human immunodeficiency virus [(HIV), perinatal exposure]^2,6;

xxii. legionellosis;

xxiii. listeriosis;

xxiv. malaria;

xxv. mumps;

xxvi. salmonellosis

xxvii. shigellosis;

xxviii. syphilis¹

xxix. syphilis [(Treponema pallidum), infection in pregnancy]^1,6

xxx. syphilis [(Treponema pallidum), perinatal exposure]^1,6;

xxxi. tetanus;

xxxii. tuberculosis³ due to Mycobacterium tuberculosis, bovis or africanum;

xxxiii. typhoid fever;

xxxiv.Vibrio infections (other than cholera); and

xxxv. Zika virus-associated birth defects.

3. Class C Diseases or Conditions which Shall Require Reporting within Five Business Days

a. Class C diseases or conditions shall include diseases or conditions of significant public health concern. The following class C diseases or conditions shall be reported to the Office of Public Health within five business days after the existence of a case, suspected case, or a positive laboratory result is known:

i. acquired immune deficiency syndrome (AIDS)²;

ii. aspergillosis;

iii. blastomycosis;

iv. campylobacteriosis;

v. chlamydial infection¹;

vi. coccidioidomycosis;

vii. cryptococcosis (Cryptococcus neoformans and C. gattii);

viii. ehrlichiosis (human granulocytic, human monocytic, Ehrlichia chaffeensis and ewingii);

ix.Enterococcus, vancomycin resistant [(VRE), invasive disease];

x. giardiasis;

xi. gonorrhea¹ (genital, oral, ophthalmic, pelvic inflammatory disease, rectal);

xii. Guillain-BarrÉ syndrome;

xiii. Hansens disease (leprosy);

xiv. hepatitis C (infection, other than as in Class B)²;

xv. histoplasmosis;

xvi. human immunodeficiency virus [(HIV) infection, other than as in class B]²;

xvii. human T lymphocyte virus (HTLV I and II) infection;

xviii. leptospirosis;

xix. Lyme disease;

xx. lymphogranuloma venereum¹;

xxi. meningitis, eosinophilic (including those due to Angiostrongylus infection);

xxii. Nipah virus infection;

xxiii. non-gonococcal urethritis;

xxiv. nontuberculous mycobacteria;

xxv. ophthalmia neonatorum;

xxvi. psittacosis;

xxvii. spotted fever rickettsioses [Rickettsia species including Rocky Mountain spotted fever (RMSF)];

xxviii. staphylococcal toxic shock syndrome;

xxix.Staphylococcus aureus, methicillin/oxacillin-resistant [(MRSA), invasive infection];

xxx. streptococcal disease, group A (invasive disease);

xxxi. streptococcal disease, group B (invasive disease);

xxxii. streptococcal toxic shock syndrome;

xxxiii.Streptococcus pneumoniae invasive disease;

xxxiv. transmissible spongiform encephalopathies (Creutzfeldt-Jakob disease and variants);

xxxv. trichinosis;

xxxvi. varicella (chickenpox); and;

xxxvii. yersiniosis.

4. Class D Special Reportable Diseases or Conditions Shall Require Reporting within Five Business Days

a. Class D diseases or conditions shall include diseases or conditions of significant public health concern. The following class D diseases or conditions shall be reported to the Office of Public Health within five business days after the existence of a case, suspected case, or a positive laboratory result is known:

i. cancer;

ii. carbon monoxide exposure and/or poisoning⁵;

iii. complications of abortion;

iv. congenital hypothyroidism⁴;

v. galactosemia;

vi. heavy metal (arsenic, cadmium, mercury) exposure and/or poisoning (all ages)⁵;

vii. hemophilia;

viii. lead exposure and/or poisoning (all ages)⁵;

ix. pesticide-related illness or injury (all ages)⁵;

x. phenylketonuria⁴;

xi. pneumoconiosis (asbestosis, berylliosis, silicosis, byssinosis, etc.) ⁵;

xii. radiation exposure, over normal limits⁵;

xiii. Reye's syndrome;

xiv. severe traumatic head injury;

xv. severe undernutrition (severe anemia, failure to thrive);

xvi. sickle-cell disease (newborns);

xvii. spinal cord injury; and

xviii. sudden infant death syndrome (SIDS).

5. Class E Reportable Occupational Diseases or Conditions Shall Require Reporting within 10 Business Days⁵

a. Class E diseases or conditions shall include any occupationally-related diseases or conditions of significant public health concern. This includes cases where the work environment is suspected to be the cause of an illness or injury or cases where the work environment is thought to be the cause of an illness exacerbation. Class E diseases or conditions shall be reported to the Office of Public Health, Section of Environmental Epidemiology and Toxicology, Occupational Health and Injury Surveillance Program, within 10 business days after existence of the case, suspected case, or positive test result is known.

E. Case reports not requiring special reporting instructions (see below) can be reported by mail or facsimile [(504) 568-8290 (fax)] on confidential disease report forms, or by phone [call (800) 256-2748 for forms and instructions] or in an electronic format acceptable to the Office of Public Health. When selecting a method of notification, the person or entity submitting a report shall be respectful of the time limitations for the report to be received by the Office of Public Health in accordance with the particular time limitations specified under classes A-D above.

1.¹Report on STD-43 Form. Report cases of syphilis with active lesions by telephone, within one business day, to (504) 568-7474.

2.²Report to the Louisiana STD/HIV Program. Visit www.hiv.dhh.louisiana.gov or call (504) 568-7474 for regional contact information.

3.³Report on CDC72.5 (f 5.2431) card.

4.⁴Report to the Louisiana Genetic Diseases Program and Louisiana Childhood Lead Poisoning Prevention Programs, www.genetics.dhh.louisiana.gov, or facsimile [(504) 568-8253 (fax)], or call (504) 568-8254 or (800) 242-3112.

5.⁵Report to the Section of Environmental Epidemiology and Toxicology, Occupational Health and Injury Surveillance Program, www.seet.dhh.louisiana.gov or call (504) 568-8150, toll free at (888) 293-7020, or by fax at (504) 568-8149.

6.⁶Report to the Louisiana STD/HIV Program on HIV/Syphilis during Pregnancy Reporting Form. Visit www.hiv.ldh.louisiana.gov or by phone at (504) 568-7474.

La. Admin. Code tit. 51, § II-105

Promulgated by the Department of Health and Hospitals, Office of Public Health, LR 28:1212 (June 2002), amended LR 32:1050 (June 2006), LR 34:2173 (October 2008), repromulgated LR 34:2582 (December 2008), LR 36:1014 (May 2010), repromulgated LR 36:1253 (June 2010), amended LR 39:1053 (April 2013), Amended LR 412653 (12/1/2015), Amended by the Department of Health, Office of Public Health, amended LR 45667 (5/1/2019), Amended LR 4751 (1/1/2021).

AUTHORITY NOTE: Promulgated in accordance with the provisions of R.S. 40:4(A)(2) and R.S. 40:5(2)(10)(11).